Ampio PharmaceuticalsAMPE
13F holders, Q1 2025 (March 31)2holders +1
1new positions
1sold out
$0.00avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Ampio Pharmaceuticals Inc. (AMPE) in their 13F filings, up 1 from Q4 2024. 1 opened new positions and 1 sold out. The largest holders were Cypress Capital Management LLC (WY) ($0) and Wealth Preservation Advisors, LLC ($0).
- Company
- Ampio Pharmaceuticals Inc.
- CUSIP
- 03209T307
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 450 shares bought and 4 shares sold, net +446 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Cypress Capital Management LLC (WY) | 0.00% | New | 450 | $0 |
| Wealth Preservation Advisors, LLC | 0.00% | — | 6 | $0 |
"% of holder's portfolio" is AMPE's weight in each manager's 13F, not the share of Ampio Pharmaceuticals Inc. the manager owns.